Sabadell Asset Management, S.A S.G.I.I.C Moderna, Inc. Transaction History
Sabadell Asset Management, S.A S.G.I.I.C
- $482 Billion
- Q2 2023
A detailed history of Sabadell Asset Management, S.A S.G.I.I.C transactions in Moderna, Inc. stock. As of the latest transaction made, Sabadell Asset Management, S.A S.G.I.I.C holds 1,416 shares of MRNA stock, worth $46,246. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,416
Previous 1,416
-0.0%
Holding current value
$46,246
Previous $219 Million
21.27%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
927Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.32 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.27 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$835 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$574 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$239 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...